Target intelligence / Profile preview

Small nucleolar RNA host gene 5 (SNHG5)

Target
SNHG5
Molecular classification
Long non-coding RNA (lncRNA), Non-protein-coding gene, Host gene for small nucleolar RNAs (snoRNAs, specifically SNORD50 family)
01

Overview

Small nucleolar RNA host gene 5 (SNHG5) is a long non-coding RNA (lncRNA) located at chromosome 6q14.3 and is 524 nucleotides in length. It serves as a host gene for specific small nucleolar RNAs (snoRNAs, particularly from the SNORD50 family). SNHG5 is primarily cytoplasmic but also found in the nucleus, where it regulates cellular processes by acting as a competing endogenous RNA (ceRNA)—sequestering microRNAs and influencing gene expression. SNHG5 is implicated in various cancers, where its overexpression or suppression influences tumor proliferation, invasion, metastasis, and drug resistance through modulation of key pathways (e.g., Wnt/β-catenin, miRNA networks). Its roles can be context-dependent, displaying both oncogenic and tumor-suppressive effects across different tissues. No direct drugs or small molecules modulate SNHG5 clinically, but it emerges as a significant prognostic biomarker and research target in oncology.

Other names
MGC16362bA33E24.2U50HGNCRNA00044LINC00044non-protein coding RNA 44long intergenic non-protein coding RNA 44C6orf160U50 host genesmall nucleolar RNA host gene 5 (non-protein coding)SNHG5
02

Mechanism of action

SNHG5 acts as a molecular sponge for microRNAs (e.g., miR-26a-5p, miR-205, miR-154-5p, miR-299, miR-1179) to regulate target gene expression involved in proliferation, metastasis, EMT, and other tumorigenic processes. Through its ceRNA network function, it indirectly modulates protein-coding gene expression (e.g., GSK3β, E2F3, ZEB2, ABCC2, PCNA). It also influences pathway activation (Wnt/β-catenin, mTOR, MAPK, etc.) contributing to tumorigenesis and drug resistance.

03

Biological functions

Competing endogenous RNA (ceRNA): Acts as a molecular sponge for various microRNAs (miRNAs), modulating their targetsRegulation of gene expression: Modulates the expression of genes involved in proliferation, apoptosis, migration, invasion, autophagy, and cell cycleOncogenic and tumor suppressor roles: Functions vary depending on the cancer type, sometimes promoting proliferation and metastasis, sometimes acting as a suppressorRegulation of signaling pathways: Impacts Wnt/β-catenin, mTOR, p38/MAPK, ROCK, and pathways related to epithelial-mesenchymal transition (EMT)Regulates expression of snoRNAs: Serves as host gene for snoRNAs involved in rRNA and mRNA processing
04

Disease associations

Cancer: Involved in hepatocellular carcinoma, breast cancer, glioma, bladder cancer, gastric cancer, colorectal cancer, leukemia (acute and chronic myeloid), endometrial cancer, melanoma, osteosarcoma, and nasopharyngeal carcinomaDrug resistance: Associated with chemoresistance (e.g., imatinib resistance in chronic myeloid leukemia)Prognostic biomarker: Correlated with tumor stage, overall survival, and disease progression in multiple cancers
05

Safety considerations

Not a drug target; thus, no safety concerns specific to drug modulation have been reported.Potential therapeutic challenge: Targeting lncRNAs with RNA-based therapeutics is still experimental and may raise delivery and specificity issues.
06

Interacting drugs

07

Biomarkers

SNHG5 expression level itselfDownstream effectors: Indirectly, markers such as PCNA, GSK3β, ABCC2, E2F3, and EMT-related proteins can reflect SNHG5 activity

Beyond the preview

Go deeper on Small nucleolar RNA host gene 5 (SNHG5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA host gene 5 (SNHG5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call